Quest Diagnostics IncorporatedDGXNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +14.55% | +12.09% | +15.19% | +13.18% | +7.06% |
| Gross Profit Growth | +15.95% | +11.93% | +17.29% | +17.02% | +6.53% |
| EBITDA Growth | +29.34% | +13.23% | +24.69% | +14.20% | -20.91% |
| Operating Income Growth | +35.21% | +15.33% | +23.38% | +16.97% | +8.31% |
| Net Income Growth | +15.63% | +13.40% | +23.14% | +8.41% | +10.36% |
| EPS Growth | +15.12% | +13.22% | +22.44% | +8.46% | +11.62% |
| EPS Diluted Growth | +14.71% | +12.79% | +21.08% | +8.54% | +11.79% |
| Weighted Average Shares Growth | -0.89% | +0.00% | +0.90% | +0.00% | +0.00% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.89% | +0.89% | +0.00% | -0.88% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -11.95% | +103.90% | +51.11% | +58.15% | +0.22% |
| Free Cash Flow Growth | -25.05% | +294.00% | +62.69% | +67.60% | -9.97% |
| Receivables Growth | +7.77% | +6.20% | +7.58% | +5.81% | +7.98% |
| Inventory Growth | -1.05% | +4.42% | +2.75% | +1.09% | +0.53% |
| Asset Growth | +15.20% | +13.21% | +15.04% | +0.63% | +0.45% |
| Book Value per Share Growth | +8.44% | +7.73% | +8.26% | +6.59% | +5.78% |
| Debt Growth | +28.98% | +22.76% | +25.47% | -8.44% | -0.09% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +15.92% | +9.17% | +19.70% | +11.83% | +4.29% |